The American Society for Radiation Oncology (ASTRO) and the Breast Cancer Research Foundation (BCRF) are offering a joint early-career award to support innovative breast cancer research led by radiation oncology investigators. The one-year grant provides protected resources for a junior faculty member or trainee to pursue a high-impact project in breast cancer radiation therapy or radiobiology, with the aim of advancing treatment through radiation science.
Eligible applicants are early-career researchers—typically junior faculty, residents, or postdoctoral fellows—working in radiation oncology, radiation biology, or medical physics with a focus on breast cancer. Applicants must hold an MD, PhD, or equivalent and plan to conduct the proposed research at a recognized institution. Multiple principal investigators are not permitted; ASTRO membership is encouraged but not required.
Research proposals must have direct relevance to breast cancer and radiation therapy, including areas such as improving radiotherapy outcomes, radiosensitizers, treatment planning, and translational radiobiology. Indirect costs are not allowed.
The award provides $100,000 USD for a one-year project. Funds may be used for salary, supplies, and other research expenses to enable the recipient to devote significant effort to the breast cancer project. The grant term is expected to run from July 1, 2026, through June 30, 2027, and all funds must be expended within that period.
The award is mentored; recipients are expected to work under the guidance of a senior investigator to support career development consistent with emerging investigator awards.
Full proposals are due January 12, 2026, via ASTRO’s ProposalCentral portal. Further information, application instructions, and program details are available on ASTRO’s ProposalCentral and on the ASTRO and BCRF websites.
Leave a Reply